NCT01953497View on ClinicalTrials.gov

Phase 1 Study of URC102 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

May 23, 2013

Primary Completion Date

December 24, 2013

Study Completion Date

July 31, 2014

Conditions
Healthy
Interventions
DRUG

URC102

DRUG

Placebo

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical
All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY